α-Ketoglutarate protects against cartilage damage via epigenetically driven metabolic reprogramming in osteoarthritis models
Open Access
- 23 December 2025
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (5)
Abstract
The link between glutaminolysis and osteoarthritis (OA) has only recently begun to be elucidated. Here, we report the association of obesity- and injury-induced cartilage damage with impaired glutaminolysis in chondrocytes. Defective glutaminolysis triggered the onset and progression of OA, with enhanced catabolism and decreased anabolism. Supplementation of α-ketoglutarate (αKG), a key component in glutaminolysis and an epigenetic factor, effectively protected cartilage against degradation in vivo via a TCA cycle– and HIF-1α–independent manner. Mechanistically, OA pathogenic factors increased H3K27me3 deposition on promoters of key glutaminolysis genes, including Slc1a5 and Gls1, leading to impaired glutaminolysis. Conversely, αKG facilitated Kdm6b-dependent H3K27me3 demethylation of not only glutaminolysis genes to rescue Gln metabolism but also Ube2o to reverse OA. Elevated Ube2o expression led to TRAF6 ubiquitination and subsequent inhibition of NF-κB signaling, thereby reversing the pathological reprogramming of glycolysis and oxidative phosphorylation and protecting against cartilage destruction. Collectively, these results demonstrated that OA pathogenic factors impair glutaminolysis through epigenetic regulation, which further exacerbate OA. Moreover, αKG restores metabolic homeostasis and alleviates OA through H3K27me3 demethylation.Keywords
Funding Information
- Natural Science Foundation of China (8257091363)
- Natural Science Foundation of China (81471798)
- Shanghai Science and Technology Innovation Action Plan (23J11900400)
This publication has 48 references indexed in Scilit:
- Altered cartilage mechanics and histology in knee osteoarthritis: relation to clinical assessment (ICRS Grade)Osteoarthritis and Cartilage, 2005
- Collagens and Cartilage Matrix HomeostasisClinical Orthopaedics and Related Research, 2004
- Osteoarthritis and cardiovascular deathAnnals of the Rheumatic Diseases, 2003
- Receptor activator NF-κB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysisAnnals of the Rheumatic Diseases, 2002
- Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- Risk factors for progression of knee osteoarthritisThe Lancet, 2001
- Col2a1-directed expression of Cre recombinase in differentiating chondrocytes in transgenic mice.2000
- TRAF6 is a signal transducer for interleukin-1Nature, 1996
- Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.Journal of Biological Chemistry, 1979
- Extracellular matrix metabolism by chondrocytes 4. Role of glutamine in glycosaminoglycan synthesis in vitro by chondrocytesBiochimica et Biophysica Acta (BBA) - General Subjects, 1978